본문 바로가기
KERD
논문KCI 등재

클론성 조혈증의 임상적 의의

Clinical Significance of Clonal Hematopoiesis

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Clonal hematopoiesis (CH) is associated with somatic mutations of the hematopoietic stem cells responsible for red blood cell formation. The incidence of CH increases with age and negative environmental factors. It is particularly common in patients on chemotherapy, and is associated with a greater than 10-fold increased risk for hematological malignancy. It also increases the risk for cardiovascular disease. Despite recent advances in molecular and genetic research, the clinical and translational aspects of disease require more attention. However, as data accumulate, prevention of disease onset and progression will improve.

Abstract

Clonal hematopoiesis (CH) is associated with somatic mutations of the hematopoietic stem cells responsible for red blood cell formation. The incidence of CH increases with age and negative environmental factors. It is particularly common in patients on chemotherapy, and is associated with a greater than 10-fold increased risk for hematological malignancy. It also increases the risk for cardiovascular disease. Despite recent advances in molecular and genetic research, the clinical and translational aspects of disease require more attention. However, as data accumulate, prevention of disease onset and progression will improve.

참고문헌 (30)

  1. Osorio FG, "Somatic mutations reveal lineage relationships and age-related mutagenesis in human hematopoiesis", Cell Rep, 25, pp.2308~2316 (2018)
  2. Steensma DP, "Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes", Blood, 126, pp.9~16 (2015)
  3. Khoury JD, "The 5th edition of the World Health Organization classification of haematolymphoid tumours : myeloid and histiocytic", dendritic neoplasms, 2022, pp.36, 1703~1719
  4. Jaiswal S, "Age-related clonal hematopoiesis associated with adverse outcomes", N Engl J Med, 371, pp.2488~2498 (2014)
  5. Jaiswal S, "Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease", N Engl J Med, 377, pp.111~121 (2017)
  6. Miller PG, "Association of clonal hematopoiesis with chronic obstructive pulmonary disease", Blood, 139, pp.357~368 (2022)
  7. Genovese G, "Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence", N Engl J Med, 371, pp.2477~2487 (2014)
  8. Xie M, "Age-related mutations associated with clonal hematopoietic expansion and malignancies", Nat Med, 20, pp.1472~1478 (2014)
  9. Soerensen JF, "Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation", Blood Adv, 4, pp.885~892 (2020)
  10. Husby S, "Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT : a national population-based cohort study", Leukemia, 34, pp.3256~3268 (2020)
  11. Slavin TP, "Association between clonal hematopoiesis and late nonrelapse mortality after autologous hematopoietic cell transplantation", Biol Blood Marrow Transplant, 25, pp.2517~2521 (2019)
  12. Ortmann CA, "Functional dominance of CHIP-mutated hematopoietic stem cells in patients undergoing autologous transplantation", Cell Rep, 27, pp.2022~2028 (2019)
  13. Gibson CJ, "Clonal hematopoiesis associated with adverse outcomes after autologous stem-cell transplantation for lymphoma", J Clin Oncol, 35, pp.1598~1605 (2017)
  14. Wilk CM, "Clonal hematopoiesis in hematopoietic stem cell transplantation", Curr Opin Hematol, 28, pp.94~100 (2021)
  15. Mouhieddine TH, "Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant", Nat Commun, 11, pp.2996~ (2020)
  16. Frick M, "Role of donor clonal hematopoiesis in allogeneic hematopoietic stem-cell transplantation", J Clin Oncol, 37, pp.375~385 (2019)
  17. Yu Q, "DNA methyltransferase 3a limits the expression of interleukin-13 in T helper 2 cells and allergic airway inflammation", Proc Natl Acad Sci U S A, 109, pp.541~546 (2012)
  18. Miller PG, "Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapy", Blood Adv, 5, pp.2982~2986 (2021)
  19. Saini NY, "Clonal hematopoiesis is associated with increased risk of severe neurotoxicity in axicabtagene ciloleucel therapy of large B-cell lymphoma", Blood Cancer Discov, 3, pp.385~393 (2022)
  20. DeZern AE, "Stem cell donors should be screened for CHIP", Blood Adv, 4, pp.784~788 (2020)
  21. Gibson CJ, "Stem cell donors should not be screened for clonal hematopoiesis", Blood Adv, 4, pp.789~792 (2020)
  22. Hasserjian RP, "Clonal hematopoiesis and measurable residual disease assessment in acute myeloid leukemia", Blood, 135, pp.1729~1738 (2020)
  23. Coombs CC, "Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes", Cell Stem Cell, 21, pp.374~382 (2017)
  24. Jensen K, "Association of clonal hematopoiesis in DNA repair genes with prostate cancer plasma cell-free DNA testing interference", JAMA Oncol, 7, pp.107~110 (2021)
  25. Malcovati L, "Clinical significance of somatic mutation in unexplained blood cytopenia", Blood, 129, pp.3371~3378 (2017)
  26. van Zeventer IA, "Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals", Blood, 135, pp.1161~1170 (2020)
  27. Moore KJ, "Macrophages in atherosclerosis : a dynamic balance", Nat Rev Immunol, 13, pp.709~721 (2013)
  28. Bonnefond A, "Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications", Nat Genet, 45, pp.1040~1043 (2013)
  29. Kim PG, "Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis", J Exp Med, 218, pp.e20211872~ (2021)
  30. Vlasschaert C, "Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease", J Am Soc Nephrol, 33, pp.985~995 (2022)

관련 논문AI추천

이 간행물의 다른 논문 (7건)